🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overall objective is to demonstrate preliminary efficacy of APX005M-car...
Status
Withdrawn
Location
NSGO-CTU
Start Date
2023-09-07
Trial ID
NCT05201001
Treatments Being Tested
This trial is a phase 1/1b study to evaluate the safety, efficacy, and tole...
Status
Completed
Location
Yale Cancer Center
Start Date
2018-06-09
Trial ID
NCT03502330
Treatments Being Tested
You are being asked to take part in this study because you have metastatic ...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2017-06-02
Trial ID
NCT02706353
Treatments Being Tested
Determine the complete pathologic complete response (pCR) rate in patients ...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2020-04-24
Trial ID
NCT04130854
This phase I trial studies the side effects and best dose of APX005M in tre...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2018-03-01
Trial ID
NCT03389802
This study is a Phase 1-2 open-label dose escalation study of the immuno-ac...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2017-07-10
Trial ID
NCT03123783
This phase II clinical trial will evaluate the safety and efficacy of addin...
Status
Completed
Location
City of Hope
Start Date
2019-03-20
Trial ID
NCT03719430
Treatments Being Tested
This study is a phase 1 open-label dose escalation study of the immuno-acti...
Status
Completed
Location
City of Hope
Start Date
2015-05
Trial ID
NCT02482168
Treatments Being Tested
The main purposes of this study are to learn how effective the study drug c...
Status
Completed
Location
University of California, Los Angeles
Start Date
2017-07-21
Trial ID
NCT03214250
Treatments Being Tested
The primary purpose of this study is to demonstrate that the NEO-PV-01 vacc...
Status
Terminated
Location
HonorHealth Research Institute
Start Date
2018-10-08
Trial ID
NCT03597282
Treatments Being Tested